Abstracts

UNIQUE EICOSANOID/LIPID PROFILES IN PREGNANT WOMEN LIVING WITH HIV IN BOTSWANA

Background: Few data exist on maternal eicosanoid/lipid profiles in pregnant women living with HIV (WLHIV) and their relationship to infant insulin sensitivity. Methods: We measured ∼800 eicosanoids/lipid subspecies via liquid chromatography mass spectrometry in fasting plasma samples collected at 24-28 weeks gestational age (GA) from pregnant WLHIV and HIV-seronegative (HIV-) pregnant women enrolled in the…

IMPACT OF THE COVID-19 PANDEMIC ON MALARIA SERVICES IN UGANDA: A TIME SERIES ANALYSIS

Background: Pregnancy is both a risk factor for P. falciparum infection and development of severe malaria and, in Uganda, its control relies heavily in the administration of intermittent preventive treatment with sulfadoxine-pyrimethamine (SP-IPTp) during antenatal care visits (ANC). COVID‐19 pandemic severely impacted health systems globally. This study aims to assess trends in delivering malaria in…

ART-DIX: A NOVEL STRATEGY TO MONITOR BROADLY NEUTRALIZING ANTIBODY ACTIVITY ON ART

Background: Therapeutic application of broadly neutralizing antibodies (bnAbs), either passively administered or elicited by therapeutic vaccines, offers new possibilities in the quest for an HIV-1 cure. One difficulty in implementing such cure strategies is the need for concurrent antiretroviral (ARV) therapy (ART). Therefore, monitoring bnAb activity under these conditions requires assays that are unaffected by…

PREDICTORS OF HIV REBOUND AFTER INTERRUPTION OF ART STARTED DURING PRIMARY INFECTION

Background: Understanding factors that affect timing of viral rebound after antiretroviral treatment (ART) interruption will accelerate efforts toward inducing sustained HIV remission. Here, we evaluated whether HIV DNA size, activity, and molecular diversity as well as peripheral T cell phenotypes prior to treatment interruption predict time to HIV rebound in individuals interrupting ART initiated during…

RESPIRATORY DISEASE FACTORS LINK WITH REDUCED SARS-CoV-2 SUSCEPTIBILITY IN PWH

Background: Despite favorable vaccine responses of people with HIV (PWH), susceptibility to SARS-CoV-2 (SCv2) infection and increased risk of COVID-19 in immunocompromised PWH continue to be of concern. Here, we searched the Swiss HIV Cohort Study (SHCS) with>9500 actively enrolled, optimally treated PWH to identify factors associated with SCv2 infection in the pre-and post-vaccination area.…

FACTORS ASSOCIATED WITH HIV-1 RESISTANCE TO INTEGRASE STRAND TRANSFER INHIBITORS

Background: Integrase strand transfer inhibitor (INSTI)-containing regimens in HIV-1-infected patients have experienced a global increase. Recently, WHO has emphasized the need to fast-track the transition to dolutegravir (DTG)-based antiretroviral (ARV) treatments. However, continued surveillance of INSTI resistance is recommended. In this study, clinical, epidemiological, and virological features associated with INSTI resistance in HIV-1-infected patients attended…

BODY MASS INDEX AND INFLAMMATION IN PEOPLE LIVING WITH HIV AND UNINFECTED CONTROLS

Background: In the present study we aimed to explore differences in inflammatory markers between people living with HIV (PLWH) and uninfected controls before and after stratification according to body-mass-index. Methods: 710 well-treated PLWH and 86 uninfected controls where included from the Copenhagen Comorbidity in HIV infection (COCOMO) study. Study participants were stratified into overweight/obese and…

TRAJECTORY OF POST-COVID NEUROCOGNITIVE RECOVERY IN PEOPLE LIVING WITH AND WITHOUT HIV

Background: Neurocognitive dysfunction is common in long COVID and in people living with HIV (PWH). It is unknown whether PWH experience different disturbances in neurocognitive function following COVID-19 compared to HIV-seronegative people. Methods: The amfAR-Johns Hopkins University COVID Recovery Study is a prospective observational cohort study consisting of four groups: participants who had SARS-CoV-2 infection…

LOW TRYPTOPHAN CATABOLISM MARKS IMMUNE PRESERVATION IN HIV+ VIREMIC NON-PROGRESSORS

Background: Viremic Non-Progressors (VNPs) is a rare subgroup of HIV+ individuals who maintain high CD4 counts despite high viremia in the absence of antiretroviral treatment (ART), resembling SIV infection in natural hosts. The mechanisms underlying this phenotype are unclear; however, the VNP phenotype has been associated with lower expression of Interferon (IFN)-stimulated genes across multiple…

AGING IMPAIRS HIV RESPONSES IN NEUTROPHILS FROM BLOOD AND THE FEMALE GENITAL TRACT

Background: Women acquire HIV through sexual transmission, with HIV incidence increasing in older women ( >50 years). However, low transmission rates per sexual act indicate local immune protection against HIV acquisition at the main portal of entry. We demonstrated that genital neutrophils respond to HIV stimulation with Neutrophil Extracellular Trap (NET)-release to inactivate the virus.…